Somatostatin v placebo in bleeding oesophageal varices: randomised trial and meta-analysis - PubMed (original) (raw)
Clinical Trial
Somatostatin v placebo in bleeding oesophageal varices: randomised trial and meta-analysis
P C Gøtzsche et al. BMJ. 1995.
Abstract
Objective: To study whether somatostatin or its derivative octreotide is more effective than placebo for treating bleeding oesophageal varices.
Methods: Randomised, double blind trial and meta-analysis with blinded analysis of data and writing of manuscripts.
Setting: Departments of medical and surgical gastroenterology in Copenhagen.
Subjects: Patients suspected of bleeding from oesophageal varices and of having cirrhosis of the liver.
Main outcome measures: Survival, number of blood transfusions, and use of Sengstaken-Blakemore tube.
Results: 86 patients were randomised; in each group 16 died within six weeks (95% confidence interval for difference in mortality--19% to 22%). There were no differences between those treated with somatostatin or placebo in median number of blood transfusions (8 v 5, P = 0.07, 0 to 4 transfusions) or in numbers of patients who needed balloon tamponade (16 v 13, P = 0.54, -11% to 28%). In a meta-analysis of three trials involving 290 patients somatostatin had no effect on survival compared with placebo (P = 0.59, odds ratio 1.16; 0.67 to 2.01). For blood transfusions and use of balloon tamponade there was heterogeneity between the trials with no convincing evidence in favour of somatostatin. No placebo controlled trials have been performed with octreotide.
Conclusion: Within the limited power of this study and meta-analysis we were unable to show a clinical benefit of somatostatin in the emergency treatment of bleeding oesophageal varices.
Comment in
- ACP J Club. 1996 Jan-Feb;124(1):12
Similar articles
- [Randomized trial and meta-analysis of somatostatin versus placebo in bleeding esophageal varices].
Gøtzsche PC, Gjørup IE, Bonnén H, Brahe NE, Becker PU, Burcharth F. Gøtzsche PC, et al. Ugeskr Laeger. 1996 Apr 22;158(17):2393-6. Ugeskr Laeger. 1996. PMID: 8685994 Clinical Trial. Danish. - Somatostatin in acute bleeding oesophageal varices. Clinical evidence.
Jenkins SA. Jenkins SA. Drugs. 1992;44 Suppl 2:36-55; discussion 70-2. doi: 10.2165/00003495-199200442-00006. Drugs. 1992. PMID: 1385069 Review. - Terlipressin vs. somatostatin in bleeding esophageal varices: a controlled, double-blind study.
Walker S, Kreichgauer HP, Bode JC. Walker S, et al. Hepatology. 1992 Jun;15(6):1023-30. doi: 10.1002/hep.1840150609. Hepatology. 1992. PMID: 1350562 Clinical Trial. - Octreotide in variceal bleeding.
Burroughs AK. Burroughs AK. Gut. 1994;35(3 Suppl):S23-7. doi: 10.1136/gut.35.3_suppl.s23. Gut. 1994. PMID: 8206396 Free PMC article. - Octreotide therapy for variceal hemorrhage.
Cello JP, Chan MF. Cello JP, et al. Digestion. 1993;54 Suppl 1:20-6. doi: 10.1159/000201071. Digestion. 1993. PMID: 8103011 Review.
Cited by
- Pro/con debate: octreotide has an important role in the treatment of gastrointestinal bleeding of unknown origin?
Arabi Y, Al Knawy B, Barkun AN, Bardou M. Arabi Y, et al. Crit Care. 2006;10(4):218. doi: 10.1186/cc4958. Crit Care. 2006. PMID: 16834764 Free PMC article. Review. - Acute variceal bleeding: general management.
Patch D, Dagher L. Patch D, et al. World J Gastroenterol. 2001 Aug;7(4):466-75. doi: 10.3748/wjg.v7.i4.466. World J Gastroenterol. 2001. PMID: 11819812 Free PMC article. Review. No abstract available. - Current management of the complications of portal hypertension: variceal bleeding and ascites.
Dib N, Oberti F, Calès P. Dib N, et al. CMAJ. 2006 May 9;174(10):1433-43. doi: 10.1503/cmaj.051700. CMAJ. 2006. PMID: 16682712 Free PMC article. Review. - Emergency sclerotherapy versus vasoactive drugs for bleeding oesophageal varices in cirrhotic patients.
D'Amico G, Pagliaro L, Pietrosi G, Tarantino I. D'Amico G, et al. Cochrane Database Syst Rev. 2010 Mar 17;2010(3):CD002233. doi: 10.1002/14651858.CD002233.pub2. Cochrane Database Syst Rev. 2010. PMID: 20238318 Free PMC article. - CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.
Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG. Moher D, et al. BMJ. 2010 Mar 23;340:c869. doi: 10.1136/bmj.c869. BMJ. 2010. PMID: 20332511 Free PMC article. No abstract available.
References
- Prog Cardiovasc Dis. 1985 Mar-Apr;27(5):335-71 - PubMed
- Gut. 1988 Feb;29(2):153-6 - PubMed
- Hepatology. 1989 Dec;10(6):958-61 - PubMed
- Gastroenterology. 1990 Nov;99(5):1388-95 - PubMed
- Drugs. 1992;44 Suppl 2:24-35; discussion 70-2 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical